JGJoão Carlos de Campos Guerra

João Carlos de Campos Guerra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


João Carlos de Campos Guerra has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Establishing a rapid-response multidisciplinary service for thrombotic microangiopathies using a model of improvement framework: perspectives from a Brazilian quaternary hospital

    by Rosana Moreira Cosentino Penteado, Adriana Cristina D'ORnelas, Nelson Martins Ferreira Junior, Carla Souza Behr Pitoli, Claudia Garcia de Barros, Sebastian Vernal, Ederson Haroldo Pereira de Almeida, Joao Carlos de Campos Guerra

    Thrombotic microangiopathies (TMA) require prompt identification and coordinated treatment because they are associated with substantial morbidity, irreversible target-organ injury, and mortality. Yet fragmented diagnostic and care pathways often delay diagnosis and lead to poorer outcomes. This Perspective article describes the design and implementation of a TMA Center of Excellence at a Brazilian quaternary hospital. This initiative aimed to design and implement a rapid-response, multidisciplinary TMA service to shorten diagnostic and treatment delays, standardize diagnosis-specific care, and establish prospective measures to evaluate clinical and operational performance. Rather than reporting outcomes, we highlight design choices, stewardship safeguards for high-cost therapies, and practical implementation enablers. Multidisciplinary teams designed and tested diagnostic and therapeutic workflows using iterative Plan–Do–Study–Act cycles. Care pathways tailored to specific patient populations were embedded into the electronic medical record (EMR). EMR integration enabled real-time alerts triggered by key laboratory results, while embedded tools, such as the PLASMIC score (platelet count, hemolysis, no active cancer, no history of solid-organ or stem-cell transplant, mean corpuscular volume, international normalized ratio, and creatinine) and therapy-specific prescription menus, guided clinical decisions. A structured indicator framework was developed to prospectively monitor time to diagnosis, adherence to clinical pathways, length of stay, and intensive care utilization. Interdisciplinary collaboration facilitated alignment across emergency, radiology, laboratory, nephrology, and hematology services. This quality improvement strategy supports the feasibility of implementing a comprehensive, multidisciplinary model for TMA management and offers a transferable blueprint that middle-income health systems can adapt.

  • Open Access

    A profile analysis of peripherally inserted central catheters implanted over 10 years in a quaternary hospital

    by Claudia Candido da Luz, Carolina Carvalho Jansen Sorbello, Estevão Araújo Epifânio, Caroline de Aguiar dos Santos, Simone Brandi, João Carlos de Campos Guerra, Nelson Wolosker

    Background: Vascular access is essential in treating patients undergoing prolonged endovenous therapy such as chemotherapy, antibiotics, and parenteral nutrition. Since the 1990s, when PICCs (peripherally inserted central catheters) appeared, vascular access options have expanded significantly, revolutionizing the treatment landscape for all types of patients. Objective: To analyze and describe the profile of the use of PICCs in a Brazilian quaternary hospital over 10 years with data collected by the infusion therapy team. Evaluating the number of PICCs implanted over the years, patients’ epidemiology and clinical characteristics, insertion details, associated complications, and the reason for removal. Methods: A retrospective cohort study that employs a quantitative, non-experimental approach to classify and statistically analyze past events associated with 21,652 PICCs implanted from January 2012 to December 2021 in a quaternary hospital at São Paulo - Brazil. All the catheters were implanted, and the data was collected by a team of nurses specializing in infusion therapy. We analyzed the number of catheters implanted over the years, insertion characteristics, patients’ epidemiology and clinical data, possible associated complications, and the reason for removal. Statistical analyses were conducted using R software (version 4.4.1) and SPSS (version 29) for Windows (IBM Corp, Armonk, NY). Results: During the specified period, 21,652 catheters were analyzed. The patients’ gender distribution was nearly balanced (48.2% versus 51.8%), and the average age was 66 years. Cardiovascular and metabolic issues were the most common comorbidities, and between 2020 and 2021, 29.3% of the sample tested positive for COVID-19. The most common location of hospitalization and implantation was the ward (31.6% - 44.2%), and the most used type of catheter was the Power Picc™ (83.9%). The estimated complication incidence density is 2.94 complications per 1,000 catheter-days. Almost all the PICCs (98,2%) were adequately located at the cavo-atrial junction after the first attempt, 82.2% of catheters were removed in the end of therapy, and the median duration of catheter use was 12 days. Conclusion: PICCs are widely employed for drug infusion, with their use growing progressively due to specialized teams’ greater availability and training. The high efficiency of these devices with a relatively low risk of complications already observed in previous studies was reinforced by the findings of this study of more than 20,000 catheters.

  • Open Access

    Impact of a Non-Mandatory Electronic Medical Record Protocol on Venous Thromboembolism Prophylaxis in Adult Hospitalized Patients: A Before-and-After Cohort Analysis of 177,856 Cases

    by Marcelo Passos Teivelis, Bruno Jeronimo Ponte, Emanuelle Lima Macedo, Isabela Monforte de Toledo, Mateus de Lima Freitas, Adriano Jose Pereira, Maria Fernanda Casino Portugal, Valéria Pinheiro de Souza, João Carlos de Campos Guerra, Nelson Wolosker

    Background: Venous thromboembolic events (VTE), which include deep vein thrombosis (DVT) and pulmonary embolism (PE) are common conditions within hospitalized patients, and is a well-known cause of in-hospital morbidity and mortality. The evidence on thromboprophylaxis benefits for reduce VTE in hospitalized patients is unequivocal. Despite that, evidence on electronic decision supports systems (e-DSS) and the real impact in VTE prevalence is still lacking. Methods: A retrospective analysis comprising all admissions between 2017 to 2021, two years before, and two years after the implementation of the e-DSS in a quaternary hospital was carried out. Patients were divided in two groups: pre-e-DSS and post-e-DSS. VTE cases were defined as any occurrence of DVT in the lower or upper limbs, superficial phlebitis, or PE. A subgroup analysis was realized based on patients’ categories of ICD-10 from admission records, including Surgical, Orthopedic, Obstetrical and Clinical admissions. The prevalence of VTE in the pre-e-DSS and post-e-DSS was compared. Results: A total of 177,851 medical records were included in the analysis. The pre-e-DSS group consisted of 104,943 admissions (59%), while the post-e-DSS 72,913 (41%). A total of 1,059 (0,60%) events of thrombosis were diagnosis in hospitalized patients. In the pre-e-DSS group 584 VTE were diagnosed, the post-e-DSS demonstrated 475. No statistical difference was demonstrated between both groups (p 0,011). The subgroup analysis considering patients from Surgical (p 0,524), Orthopedic (p 0,034) and Obstetrical (p 0,870) admissions demonstrated no statistical difference. The Clinical admissions demonstrated an increase in VTE in the group post-e-DSS (p<0,001). Conclusion: The use of a non-mandatory electronic protocol for managing venous thromboembolism in patients’ electronic records is insufficient to reduce VTE incidence among hospitalized patients across all groups, including Surgical, Clinical, Orthopedic, and Obstetrical.

  • Open Access

    Hemorrhagic code protocol, a successful case in the patient blood management model for patients with severe hemorrhages

    by João Carlos de Campos Guerra, Michele Jaures, Roseny dos Reis Rodrigues, Adriana Serra Cypriano, Daniel Tavares Malheiro, Anna Carolina Batista Dantas, Fernanda Paulino Fernandes, Neila Maria Marques Negrini, Vanessa Damazio Teich


  • Open Access

    COVID-19-associated coagulopathy and acute kidney injury in critically ill patients

    by Bruno Caldin da Silva, Ricardo Luiz Cordioli, Bento Fortunato Cardoso dos Santos, João Carlos de Campos Guerra, Roseny dos Reis Rodrigues, Guilherme Martins de Souza, Carolina Ashihara, Thais Dias Midega, Niklas Söderberg Campos, Bárbara Vieira Carneiro, et al.

    Highlights 43.4% of the cohort developed acute kidney injury. D-dimer and fibrinogen levels were high in both groups. Rotational thromboelastometry data were similar between groups. Serum levels of antithrombin activity and protein C were lower in patients who developed acute kidney injury. Objective The incidence of thrombotic events and acute kidney injury is high in critically ill patients with COVID-19. We aimed to evaluate and compare the coagulation profiles of patients with COVID-19 developing acute kidney injury versus those who


  • Epidemiology of the use of inferior vena cava filters in Brazil between 2008 and 2019

    by Andressa Cristina Sposato Louzada, Dafne Braga Diamante Leiderman, Marcelo Fiorelli Alexandrino da Silva, Maria Fernanda Cassino Portugal, João Carlos de Campos Guerra, Marcelo Passos Teivelis, Nelson Wolosker

    Objectives: The primary objective was to study the totality of inferior vena cava filter placements and their temporal and geographic distribution in the Brazilian Public Health System, which insures more than 160 million Brazilians. The secondary objective was to analyze in-hospital mortality after filter placement and deaths due to pulmonary embolism. Methods: Public and open data on in-hospital mortality due to pulmonary embolism and on rates of inferior vena cava filters placement, its associated diagnosis, and in-hospital mortality in Brazilian public hospitals between January 2008 and December 2019 were extracted from Ministry of Health databases. Results: A total of 9108 inferior vena cava filters were placed, 98.18% of which was therapeutic. We observed a significant increase in the use of these devices over the years, from 508 inferior vena cava filters placed in 2008 to 965 in 2019. In-hospital mortality rate in patients who received inferior vena cava filters was 6.21%, stable over time, and 96.64% of causes of these causes were attributed to venous thromboembolism. The in-hospital mortality rate due to pulmonary embolism, regardless of the placement of vena cava filters, has increased significantly. Conclusion: We observed a low but increasing rate of inferior vena cava filter placements in Brazil between 2008 and 2019, most indications were therapeutic. Our findings were heterogeneous across Brazilian regions and contrasted to those observed in the USA, which is likely due to cultural and socioeconomic factors.


  • Open Access

    Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor

    by Thiago Guarato Rodrigues Costa, Marcelo Katz, Pedro Alves Lemos, João Carlos de Campos Guerra, Marcelo Franken, Antonio Eduardo Pereira Pesaro

    Objective: Low platelet reactivity levels are associated with higher risk of bleeding in patients receiving dual antiplatelet therapy relative to patients with optimal platelet blockade. This study set out to evaluate the prevalence of low platelet reactivity in patients with acute myocardial infarction treated with ticagrelor and aspirin. Methods: Patients admitted with acute myocardial infarction who were already undergoing dual antiplatelet therapy with aspirin and ticagrelor were enrolled. Blood samples were collected 1 hour before and 2 hours after


  • Open Access

    Bleeding management after implementation of the Hemorrhage Code (Code H) at the Hospital Israelita Albert Einstein, São Paulo, Brazil

    by Michele Jaures, Neila Maria Marques Negrini Pigatti, Roseny dos Reis Rodrigues, Fernanda Paulino Fernandes, João Carlos de Campos Guerra

    Objective To describe the implementation of a care protocol based on rapid response teams, for management and resolution of bleeding. Methods A hospital protocol called Hemorrhage Code (Code H) was devised and developed. In a flow line, a multidisciplinary team provides comprehensive, fast and effective care to the patient with a severe hemorrhagic condition. In another flow line, professionals based at the hospital pharmacy focus on identifying patients at risk of bleeding, to avoid this event. Several hospital professionals [...] ABSTRACT Objective To describe the implementation of a care protocol based on rapid response teams, for management and resolution of bleeding. Methods A hospital protocol called Hemorrhage Code (Code H) was devised and developed. In a flow line, a multidisciplinary team provides comprehensive, fast and effective care to the patient with a severe hemorrhagic condition. In another flow line, professionals based at the hospital pharmacy focus on identifying patients at risk of bleeding, to avoid this event. Several hospital professionals


  • Open Access

    Comment to: Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection

    by Thiago Domingos Corrêa, Gustavo Faissol Janot de Matos, Bruno de Arruda Bravim, Ricardo Luiz Cordioli, Alejandra del Pilar Gallardo Garrido, Murillo Santucci Cesar de Assuncao, Carmen Silvia Valente Barbas, Karina Tavares Timenetsky, Roseny dos Reis Rodrigues, Hélio Penna Guimarães, et al.

    Dear Editor, In this issue of einstein journal (São Paulo), Corrêa et al., reported intensive support recommendations for critically-ill patients with suspected or confirmed infection by the new coronavirus (COVID-19).() Based on preliminary demonstration of efficacy of chloroquine, the authors suggested the use of hydroxychloroquine in monotherapy or combined with a macrolide (azithromycin or clarithromycin), to treat severe patients with COVID-19, admitted to the intensive care unit (ICU), to inhibit in vitro replication of severe acute respiratory syndrome coronavirus 2 [...] Dear Editor, In this issue of einstein journal (São Paulo), Corrêa et al., reported intensive support recommendations for critically-ill patients with suspected or confirmed infection by the new coronavirus (COVID-19).() Based on preliminary demonstration of efficacy of chloroquine, the authors suggested the use of hydroxychloroquine in monotherapy or combined with a macrolide (azithromycin or clarithromycin), to treat severe patients with COVID-19, admitted to the intensive care unit (ICU), to inhibit in vitro replication of severe acute respiratory syndrome coronavirus 2


  • Open Access

    Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection

    by Thiago Domingos Corrêa, Gustavo Faissol Janot de Matos, Bruno de Arruda Bravim, Ricardo Luiz Cordioli, Alejandra del Pilar Gallardo Garrido, Murillo Santucci Cesar de Assuncao, Carmen Silvia Valente Barbas, Karina Tavares Timenetsky, Roseny dos Reis Rodrigues, Hélio Penna Guimarães, et al.

    In December 2019, a series of patients with severe pneumonia were identified in Wuhan, Hubei province, China, who progressed to severe acute respiratory syndrome and acute respiratory distress syndrome. Subsequently, COVID-19 was attributed to a new betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 20% of patients diagnosed as COVID-19 develop severe forms of the disease, including acute hypoxemic respiratory failure, severe acute respiratory syndrome, acute respiratory distress syndrome and acute renal failure and require intensive care. There is no randomized controlled clinical trial addressing potential therapies for patients with confirmed COVID-19 infection at the time of publishing these treatment recommendations. Therefore, these recommendations are based predominantly on the opinion of experts (level C of recommendation).